MedTrace Logo

Focused Ultrasound and Exosomes to Treat Depression, Anxiety, and Dementias

NCT04202770 · Status: SUSPENDED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2022-09-28

No results posted yet for this study

Summary

This study is designed to evaluate the safety and efficacy of exosome deployment with concurrent transcranial ultrasound in patients with refractory, treatment resistant depression, anxiety, and neurodegenerative dementia.

Conditions

Interventions

OTHER

Exosomes

Focused ultrasound delivery of intravenously-infused exosomes

Sponsors & Collaborators

  • Neurological Associates of West Los Angeles

    lead OTHER

Principal Investigators

  • Sheldon Jordan, M.D. · Neurological Associates of West Los Angeles

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-01
Primary Completion
2023-12-31
Completion
2024-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04202770 on ClinicalTrials.gov